跳至主要内容
临床试验/CTRI/2017/05/008716
CTRI/2017/05/008716招募中未知

Multi-Centric Screening of Breast Cancer Patients to Determine Efficiency and to Assess Sensitivity & Accuracy of Pandora CDx MammoAlertTM in Screening of Breast Cancer.

POC Medical Systems Inc0 个研究点目标入组 2,400 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
2,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a) Sex female.
  • b) Age between 18 and above.
  • c) Ability to give informed consent. Written informed consent by the patient/patientâ??s legally acceptable representative (LAR) for donating blood sample.
  • d) Documented absence of cancer, other than breast cancer

排除标准

  • a) Other malignancy besides breast cancer in the 5 years prior to obtaining the sample.
  • b) Therapies for breast cancer that have been administered in less than 1 year prior to obtaining the sample.
  • c) Any condition (including psychiatric), which in the Investigatorâ??s opinion, places the patient at undue risk by participating in the study.

研究者

发起方
POC Medical Systems Inc

相似试验